Another group from the United Kingdom (UK) analyzed cervicovaginal samples of 399 patients with ZSCAN12 and GYPC region methylation and found a sensitivity of 90.9% and specificity of 92.1% for endometrial cancer detection [16]. Here, ZSCAN12 is linked to endometrial cancer.